BROADWOOD PARTNERS LP Insider Trading $BTX Lineage Cell Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BROADWOOD PARTNERS LP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BROADWOOD PARTNERS LP. BROADWOOD PARTNERS LP is 10% Owner in COMARCO INC ($CMRO) and 10% Owner in STAAR SURGICAL CO ($STAA) and Director in BIOTIME INC ($BTX) and in Asterias Biotherapeutics, Inc. ($ASTY) and 10% Owner in OncoCyte Corp ($OCX).
BROADWOOD PARTNERS LP in Lineage Cell Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BROADWOOD PARTNERS LP: Director
Holdings: 33,990,826 shares
Current Value: $104,011,928
Latest Transaction: Aug 15 2019
$BTX Market Capitalization: $309.34M
$BTX Previous Close: $3.06
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BROADWOOD PARTNERS LP in Lineage Cell Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ASTY, CMRO, BTX, OCX, STAA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 15 2019 | BTX | Lineage Cell Thera ... | BROADWOOD PARTNERS, L.P. | Director | Buy | P | 0.97 | 13,146 | 12,717 | 34,005,379 | 34 M to 34 M (+0.04 %) |
| Aug 15 2019 | BTX | Lineage Cell Thera ... | BROADWOOD PARTNERS, L.P. | Director | Buy | P | 0.98 | 1,407 | 1,379 | 33,992,233 | 34 M to 34 M (0.00 %) |
| Aug 15 2019 | BTX | Lineage Cell Thera ... | BROADWOOD PARTNERS, L.P. | Director | Buy | P | 0.99 | 10,000 | 9,949 | 33,990,826 | 34 M to 34 M (+0.03 %) |
| Apr 18 2019 | BTX | BIOTIME INC | BROADWOOD PARTNERS, L.P. | Director | Buy | J | 1.32 | 251,835 | 332,397 | 33,980,826 | 33.7 M to 34 M (+0.75 %) |
| Mar 12 2019 | BTX | BIOTIME INC | BROADWOOD PARTNERS, L.P. | Director | Buy | J | 0.00 | 3,757,430 | 0 | 33,728,991 | 30 M to 33.7 M (+12.54 %) |
| Oct 17 2017 | BTX | BIOTIME INC | BROADWOOD PARTNERS, L.P. | Director | Buy | P | 2.60 | 2,692,307 | 6,999,998 | 29,971,561 | 27.3 M to 30 M (+9.87 %) |
| Aug 24 2017 | BTX | BIOTIME INC | BROADWOOD PARTNERS, L.P. | Director | Buy | P | 2.60 | 10,000 | 25,955 | 27,279,254 | 27.3 M to 27.3 M (+0.04 %) |
| Aug 02 2017 | BTX | BIOTIME INC | BROADWOOD PARTNERS, L.P. | Director | Buy | P | 2.80 | 150,000 | 420,000 | 27,269,254 | 27.1 M to 27.3 M (+0.55 %) |
| Feb 17 2017 | BTX | BIOTIME INC | BROADWOOD PARTNERS, L.P. | Director | Buy | P | 2.70 | 2,222,222 | 5,999,999 | 27,119,254 | 24.9 M to 27.1 M (+8.93 %) |
| Jun 23 2016 | BTX | BIOTIME INC | BROADWOOD PARTNERS LP | Director | Buy | P | 2.39 | 2,732,636 | 6,531,000 | 24,897,032 | 22.2 M to 24.9 M (+12.33 %) |
| Jan 22 2016 | BTX | BIOTIME INC | BROADWOOD PARTNERS LP | Director | Buy | P | 2.35 | 300,000 | 705,000 | 22,164,396 | 21.9 M to 22.2 M (+1.37 %) |
| Oct 06 2015 | BTX | BIOTIME INC | BROADWOOD PARTNERS LP | Director | Buy | J | 3.19 | 1,600,000 | 5,104,000 | 21,864,396 | 20.3 M to 21.9 M (+7.90 %) |
| Sep 16 2015 | BTX | BIOTIME INC | BROADWOOD PARTNERS LP | Director | Buy | J | 3.29 | 2,431,611 | 8,000,000 | 20,264,396 | 17.8 M to 20.3 M (+13.64 %) |
Page: 1